COMPANY OVERVIEW

None

---

LOCATION

---

THERAPEUTIC AREAS

---

WEBSITE

https://www.myeloidtx.com/

---

CAREER WEBSITE

https://www.myeloidtx.com/myeloidtx-careers

---

SOCIAL MEDIA

---

INVESTORS

---

PRESS RELEASES

Sep 12, 2023

Myeloid Therapeutics Initiates Patient Dosing with MT-302, a Novel TROP2-Targeting RNA CAR, in Phase 1 Study for Advanced or Metastatic Epithelial Tumors

Aug 31, 2023

Myeloid Therapeutics to Participate at Upcoming Investor Conferences

May 23, 2023

Myeloid Therapeutics to Participate at SVB Securities Biopharma Company Connect Event

May 18, 2023

Myeloid Therapeutics Announces $73 Million Financing to Advance mRNA-based Immunotherapy Pipeline

Apr 17, 2023

Myeloid Therapeutics Presents Late-Breaking Data on Multiple Platforms at the American Association for Cancer Research (AACR) 2023 Annual Meeting

For More Press Releases

---